Concepedia

Publication | Closed Access

Rates of discontinuation and change of glaucoma therapy in a managed care setting.

63

Citations

0

References

2002

Year

Joshua J. Spooner, Michael Bullano, Laurence I Ikeda, Tara R. Cockerham, W.J. Waugh, Thomas L. Johnson, Essy Mozaffari
PubMed

Abstract

This study indicates that latanoprost therapy results in a lower rate of discontinuation or change compared to patients started on betaxolol, brimonidine, or timolol.